A detailed history of Xtx Topco LTD transactions in Orgenesis Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 16,280 shares of ORGS stock, worth $86,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,280
Holding current value
$86,284
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.39 - $0.63 $6,349 - $10,256
16,280 New
16,280 $9,000
Q4 2023

Feb 13, 2024

BUY
$0.44 - $0.96 $5,180 - $11,303
11,774 New
11,774 $5,000

Others Institutions Holding ORGS

About Orgenesis Inc.


  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $135M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.